With an active file of over 34 000 cancer patients, and their associated research centers, the Centre de Recherche en Cancérologie de Marseille (CRCM), the Center for Research in Biological Oncology and Oncopharmacology (CRO2), the Cancer, Biomedicine and Society (CanBioS) socio-economics research team, and the Public Health and Chronic Disease research team (EA3279). The CRCM includes 250 IPC/Inserm/CNRS/Aix Marseille University members of staff working on basic and translational research with a strong focus on the core pathologies of the IPC (breast cancer, hematology and pancreatic cancer). The CRO2 hosts Inserm/Aix Marseille University research teams, 120 people altogether, mainly focusing on brain and pancreatic tumours. IPC, AP-HM, CRCM and CRO2 have set up many collaborative projects and they share strategic platforms, such as the tumor bank and the Proteomics platform and databases hosted by the Data Management and analysis center of IPC-PACA. The clinical trials of the SIRIC are coordinated by the Department of Clinical Research and Innovations of IPC and by the Delegation for Clinical Research and Innovations of AP-HM respectively.
Pancreatic cancer day: October 13th